Skip to search formSkip to main contentSkip to account menu

26 ML ustekinumab 5 MG/ML Injection [Stelara]

Known as: Stelara 130 MG in 26 ML Injection, Stelara 130 MG per 26 ML Injection, 26 ML Stelara 5 MG/ML Injection 
National Institutes of Health

Related topics

Related topics

9 relations
Edetic Acid, Disodium SaltHISTIDINE MONOHYDROCHLORIDE MONOHYDRATEHistidineInjection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
N24 Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series
2018
2018
NOAKs: Riskante Unterdosierung
Eine 25-jährige Crohn-Patientin hatte unter 15 mg Prednisolon täglich zunehmende Beschwerden. Trotz einer erapie mit Azathioprin… 
2018
2018
Was tun, wenn Azathioprin nicht hilft?
Eine 25-jährige Crohn-Patientin hatte unter 15 mg Prednisolon täglich zunehmende Beschwerden. Trotz einer erapie mit Azathioprin… 
2018
2018
Phyto punktet beim Sex
Eine 25-jährige Crohn-Patientin hatte unter 15 mg Prednisolon täglich zunehmende Beschwerden. Trotz einer erapie mit Azathioprin… 
2018
2018
Risk of malignancies associated with ustekinumab
A recently published report by Florek et al.1 associates malignancies with ustekinumab (STELARA®) treatment. Janssen emphasizes… 
Review
2017
Review
2017
Update on Ustekinumab for Psoriasis
Purpose of ReviewThis review will highlight the latest data on ustekinumab, as well as provide anecdotal evidence and insight… 
2016
2016
Ustekinumab in adolescents with moderate to severe plaque psoriasis: a guide to its use
Ustekinumab (Stelara®), the only approved biological agent that acts as an antagonist of interleukin-12/23, is an effective and… 
2015
2015
Pneumopathie à éosinophiles chez un patient atteint de psoriasis en plaques traité par ustékinumab
2014
2014
Pneumopathie à éosinophiles chez un patient atteint de psoriasis en plaques
2012
2012
Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
Ustekinumab (Stelara®) is a human monoclonal antibody that binds to the p40 subunit common to both interleukin (IL)-12 and IL-23… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)